: The AMEDEO Literature Guide

Home The Word Brain

My Amedeo

FAQ

Privacy

About

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

Migraine

Free Subscription

Articles published in Cephalalgia
Retrieve available abstracts of 310 articles:
HTML format

Single Articles

April 2024

RATTANAWONG W, Rapoport A, Srikiatkhachorn A
Medication "underuse" headache.
Cephalalgia. 2024;44:3331024241245658.
PubMed Abstract available

March 2024

PASCUAL-MATO M, Garate G, de Prado-Tejerina C, Garcia MJ, et al
Increased prevalence of migraine in women with inflammatory bowel disease: A cross-sectional study.
Cephalalgia. 2024;44:3331024241233979.
PubMed Abstract available

SELNTIGIA A, Exacoustos C, Ortoleva C, Russo C, et al
Correlation between endometriosis and migraine features: Results from a prospective case-control study.
Cephalalgia. 2024;44:3331024241235210.
PubMed Abstract available

PORRECA F, Navratilova E, Hirman J, van den Brink AM, et al
Evaluation of outcomes of calcitonin gene-related peptide (CGRP)-targeting therapies for acute and preventive migraine treatment based on patient sex.
Cephalalgia. 2024;44:3331024241238153.
PubMed Abstract available

THOMSEN AV, Al-Karagholi MA, Hougaard A, Ostrowski SR, et al
Investigations of the migraine-provoking effect of levcromakalim in patients with migraine with aura.
Cephalalgia. 2024;44:3331024241237247.
PubMed Abstract available

LAMAS PEREZ R, Millan-Vazquez M, Gonzalez-Oria C
Efficacy and safety of galcanezumab as chronic cluster headache preventive treatment under real world conditions: Observational prospective study.
Cephalalgia. 2024;44:3331024231226181.
PubMed Abstract available

SACCO S, Porreca F
Breaking barriers in migraine care: Advancing gender medicine to bridge the gap for men.
Cephalalgia. 2024;44:3331024241238157.
PubMed

DIENER HC, May A
New migraine drugs: A critical appraisal of the reason why the majority of migraine patients do not receive an adequate medication.
Cephalalgia. 2024;44:3331024241228605.
PubMed Abstract available

ASHINA H, Diener HC, Tassorelli C, Scher AI, et al
Guidelines of the International Headache Society for controlled trials of pharmacological preventive treatment for persistent post-traumatic headache attributed to mild traumatic brain injury.
Cephalalgia. 2024;44:3331024241234068.
PubMed Abstract available

February 2024

TORRES-FERRUS M, Gallardo VJ, Alpuente A, Caronna E, et al
Improvement of migraine depressive symptoms is not related to headache frequency: exploring the impact of anti-CGRP therapies.
Cephalalgia. 2024;44:3331024231222923.
PubMed Abstract available

THURAIAIYAH J, Ashina H, Christensen RH, Al-Khazali HM, et al
Premonitory symptoms in migraine: A REFORM Study.
Cephalalgia. 2024;44:3331024231223979.
PubMed Abstract available

PHILLIPS K, Clerkin-Oliver C, Nirantharakumar K, Crowe FL, et al
How migraine and its associated treatment impact on pregnancy outcomes: Umbrella review with updated systematic review and meta-analysis.
Cephalalgia. 2024;44:3331024241229410.
PubMed Abstract available

VIANA M, Hougaard A, Tronvik E, Winnberg IG, et al
Visual migraine aura iconography: A multicentre, cross-sectional study of individuals with migraine with aura.
Cephalalgia. 2024;44:3331024241234809.
PubMed Abstract available

IKUMI N, Marti-Marca A, Torre-Sune A, Cerda-Company X, et al
Quantifying sensory thresholds along the migraine cycle: An exploratory longitudinal study.
Cephalalgia. 2024;44:3331024241230279.
PubMed Abstract available

TASSORELLI C, Onishchenko K, Halker Singh RB, Duan M, et al
Comparative efficacy, quality of life, safety, and tolerability of atogepant and rimegepant in migraine prevention: A matching-adjusted indirect comparison analysis.
Cephalalgia. 2024;44:3331024241235156.
PubMed Abstract available

SHEWALE AR, Brandenburg JA, Burslem K, Lipton RB, et al
Health care resource utilization and costs associated with diagnosed medication overuse headache and potential acute medication overuse in individuals with migraine.
Cephalalgia. 2024;44:3331024241235139.
PubMed Abstract available

January 2024

COPPOLA G, Renzo AD, Parisi V, Serrao M, et al
Comment on "Lack of reproducibility of resting-state functional MRI findings in migraine with aura".
Cephalalgia. 2024;44:3331024231225186.
PubMed

PICO MJ, Badri M, Michalak N, Siefferman JW, et al
Systemic allergic reaction to galcanezumab (emgality): a case report.
Cephalalgia. 2024;44:3331024231222914.
PubMed Abstract available

NIDDAM DM, Lai KL, Hsiao YT, Wang YF, et al
Grey matter structure within the visual networks in migraine with aura: multivariate and univariate analyses.
Cephalalgia. 2024;44:3331024231222637.
PubMed Abstract available

BUGGE NS, Grotta Vetvik K, Alstadhaug KB, Braaten T, et al
Cumulative exposure to estrogen may increase the risk of migraine in women.
Cephalalgia. 2024;44:3331024231225972.
PubMed Abstract available

FLORESCU AM, Lannov LV, Younis S, Cullum CK, et al
No wearing-off effect of erenumab or fremanezumab for chronic migraine prevention: a single-center, real-world, observational study.
Cephalalgia. 2024;44:3331024231222915.
PubMed Abstract available

RAHMAN SM, Luebke AE
Calcitonin gene-related peptide receptor antagonism reduces motion sickness indicators in mouse migraine models.
Cephalalgia. 2024;44:3331024231223971.
PubMed Abstract available

RAFFAELLI B, Do TP, Chaudhry BA, Amin FM, et al
Activation of ATP-sensitive potassium channels triggers migraine attacks independent of calcitonin gene-related peptide receptors: a randomized placebo-controlled trial.
Cephalalgia. 2024;44:3331024231222916.
PubMed Abstract available

MONTE G, Papetti L, Ursitti F, Sforza G, et al
Childhood primary stabbing headache: A double center study.
Cephalalgia. 2024;44:3331024231225974.
PubMed Abstract available

KRISTOFFERSEN ES, Pallesen S, Waage S, Bjorvatn B, et al
The long-term effect of work schedule, shift work disorder, insomnia and restless legs syndrome on headache among nurses: A prospective longitudinal cohort study.
Cephalalgia. 2024;44:3331024231226323.
PubMed Abstract available

December 2023

BASEDAU H, Ornello R, Matteis E, Davaasuren B, et al
Placebo and nocebo in the treatment of migraine: How much does real world effectiveness depend on contextual effects?
Cephalalgia. 2023;43:3331024231218392.
PubMed Abstract available

PENSATO U, Cevoli S, Pierangeli G, Cortelli P, et al
The evolutionary meaning of migraine.
Cephalalgia. 2023;43:3331024231209303.
PubMed Abstract available

TEZUKA T, Shibata M, Hanaoka H, Izawa Y, et al
Systemic lupus erythematosus mimicking retinal migraine: a case report.
Cephalalgia. 2023;43:3331024231219477.
PubMed Abstract available

DOBOS D, Kokonyei G, Gyebnar G, Szabo E, et al
Microstructural differences in migraine: A diffusion-tensor imaging study.
Cephalalgia. 2023;43:3331024231216456.
PubMed Abstract available

AL-KARAGHOLI MA
Targeting CGRP pathways and aura: A peripheral site with a central effect.
Cephalalgia. 2023;43:3331024231212895.
PubMed Abstract available

CHRISTOPHERSEN P, Dyhring T
The shortcoming of using glibenclamide in exploratory clinical headache provocation studies.
Cephalalgia. 2023;43:3331024231219475.
PubMed Abstract available

November 2023

VAN DER AREND B, Terwindt GM
Response to Letter to the Editor, Comment on "Effect of COVID vaccinations on monthly migraine days".
Cephalalgia. 2023;43:3331024231208123.
PubMed

DAUNGSUPAWONG H, Wiwanitkit V
Comment on "Effect of COVID vaccination on monthly migraine days".
Cephalalgia. 2023;43:3331024231208121.
PubMed

AL-KHAZALI HM, Christensen RH, Dodick DW, Chaudhry BA, et al
Hypersensitivity to opening of ATP-sensitive potassium channels in post-traumatic headache.
Cephalalgia. 2023;43:3331024231210930.
PubMed Abstract available

NAVARRO-PEREZ MP, Santos-Lasaosa S, Olesen J
Evaluation of the ICHD-3 diagnostic criteria for cardiac cephalalgia and new proposal.
Cephalalgia. 2023;43:3331024231202243.
PubMed Abstract available

HOUGAARD A, Gaist D, Garde E, Iversen P, et al
Lack of reproducibility of resting-state functional MRI findings in migraine with aura.
Cephalalgia. 2023;43:3331024231212574.
PubMed Abstract available

BAHRA A
Paroxysmal hemicrania and hemicrania continua: Review on pathophysiology, clinical features and treatment.
Cephalalgia. 2023;43:3331024231214239.
PubMed Abstract available

GARCIA-AZORIN D, Santana-Lopez L, Lozano-Alonso JE, Ordax-Diez A, et al
InfluenCEF study: Clinical phenotype and duration of headache attributed to influenza infection.
Cephalalgia. 2023;43:3331024231212900.
PubMed Abstract available

ASHINA M, Mitsikostas DD, Amin FM, Kokturk P, et al
Real-world effectiveness of fremanezumab for the preventive treatment of migraine: Interim analysis of the pan-European, prospective, observational, phase 4 PEARL study.
Cephalalgia. 2023;43:3331024231214987.
PubMed Abstract available

October 2023

SEBASTIANELLI G, Casillo F, Abagnale C, Renzo AD, et al
Central sensitization mechanisms in chronic migraine with medication overuse headache: a study of thalamocortical activation and lateral cortical inhibition.
Cephalalgia. 2023;43:3331024231202240.
PubMed Abstract available

AL-KHAZALI HM, Ashina H, Christensen RH, Wiggers A, et al
An exploratory analysis of clinical and sociodemographic factors in CGRP-induced migraine attacks: A REFORM study.
Cephalalgia. 2023;43:3331024231206375.
PubMed Abstract available

DEV P, Favas TT, Jaiswal R, Cyriac M, et al
The effect of low dose thyroid replacement therapy in patients with episodic migraine and subclinical hypothyroidism: A randomised placebo-controlled trial.
Cephalalgia. 2023;43:3331024231182684.
PubMed Abstract available

CHUANG CH, Li JY, King JT, Chen WT, et al
Abnormal heart rate variability and its application in predicting treatment efficacy in patients with chronic migraine: An exploratory study.
Cephalalgia. 2023;43:3331024231206781.
PubMed Abstract available

CHRISTENSEN RH, Eigenbrodt AK, Ashina H, Steiner TJ, et al
What proportion of people with migraine report postdromal symptoms? A systematic review and meta-analysis of observational studies.
Cephalalgia. 2023;43:3331024231206376.
PubMed Abstract available

KUAN AS, Chen SP, Wang YF, Wang SJ, et al
Prolonged headache with vaccine- and dose-specific headache pattern associated with vaccine against SARS-CoV-2 in patients with migraine.
Cephalalgia. 2023;43:3331024231208110.
PubMed Abstract available

ZLOOF Y, Tsur AM, Simchoni M, Derazne E, et al
Body mass index and migraine in adolescence: A nationwide study.
Cephalalgia. 2023;43:3331024231209309.
PubMed Abstract available

ALEKSOVSKA K, Hershey AD, Deen M, Icco R, et al
Efficacy and safety of monoclonal antibodies targeting CGRP in migraine prevention. GRADE tables elaborated by the ad hoc working group of the International Headache Society.
Cephalalgia. 2023;43:3331024231206162.
PubMed Abstract available

BELIN AC, Barloese MC
The genetics and chronobiology of cluster headache.
Cephalalgia. 2023;43:3331024231208126.
PubMed Abstract available

September 2023

VAN DER AREND BWH, Bloemhof MM, van der Schoor AG, van Zwet EW, et al
Effect of COVID vaccination on monthly migraine days: a longitudinal cohort study.
Cephalalgia. 2023;43:3331024231198792.
PubMed Abstract available

August 2023

ALPUENTE A, Torre-Sune A, Caronna E, Gine-Cipres E, et al
Impact of anti-CGRP monoclonal antibodies on migraine attack accompanying symptoms: A real-world evidence study.
Cephalalgia. 2023;43:3331024231177636.
PubMed Abstract available

LA ROCCA M, Laporta A, Clemente L, Ammendola E, et al
Galcanezumab treatment changes visual related EEG connectivity patterns in migraine patients.
Cephalalgia. 2023;43:3331024231189751.
PubMed Abstract available

ADAM I, Elmugabil A, AlHabardi N
History of maternal migraine and its association with preeclampsia: A case-control study in a low-resource setting in Sudan, Africa.
Cephalalgia. 2023;43:3000605231193823.
PubMed Abstract available

PULEDDA F, Vigano A, Sebastianelli G, Parisi V, et al
Electrophysiological findings in migraine may reflect abnormal synaptic plasticity mechanisms: A narrative review.
Cephalalgia. 2023;43:3331024231195780.
PubMed Abstract available

LIPTON RB, Halker Singh RB, Mechtler L, McVige J, et al
Patient-reported migraine-specific quality of life, activity impairment and headache impact with once-daily atogepant for preventive treatment of migraine in a randomized, 52-week trial.
Cephalalgia. 2023;51:3331024231190296.
PubMed Abstract available

July 2023

PATTERSON GENTILE C, Aguirre GK, Hershey AD, Szperka CL, et al
Symptoms associated with headache in youth.
Cephalalgia. 2023;43:3331024231187162.
PubMed Abstract available

June 2023

VERHAGEN IE, van der Arend BW, van Casteren DS, Thiermann NJ, et al
Migraine with and without aura in relation to the menstrual cycle and other hormonal milestones: A prospective cohort study.
Cephalalgia. 2023;43:3331024231164322.
PubMed Abstract available

PELZER N, de Boer I, van den Maagdenberg AMJM, Terwindt GM, et al
Neurological and psychiatric comorbidities of migraine: Concepts and future perspectives.
Cephalalgia. 2023;43:3331024231180564.
PubMed Abstract available

KLAN T, Gaul C, Liesering-Latta E, Witthoft M, et al
Behavioral treatment for migraine prophylaxis in adults: Moderator analysis of a randomized controlled trial.
Cephalalgia. 2023;43:3331024231178237.
PubMed Abstract available

BERTZ R, Bhardwaj R, Morris BA, Ashbrenner E, et al
A placebo-controlled, randomized, single and multiple dose study to evaluate the safety, tolerability, and pharmacokinetics of rimegepant in healthy participants.
Cephalalgia. 2023;43:3331024231179131.
PubMed Abstract available

BUTURE A, Tomkins EM, Shukralla A, Troy E, et al
Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent headache or persistent post-traumatic headache in the
Cephalalgia. 2023;43:3331024231182126.
PubMed Abstract available

ADAMS AM, Buse DC, Leroux E, Lanteri-Minet M, et al
Chronic Migraine Epidemiology and Outcomes - International (CaMEO-I) Study: Methods and multi-country baseline findings for diagnosis rates and care.
Cephalalgia. 2023;43:3331024231180611.
PubMed Abstract available

CARCEL C, Haghdoost F, Shen J, Nanda P, et al
The effect of blood pressure lowering medications on the prevention of episodic migraine: A systematic review and meta-analysis.
Cephalalgia. 2023;43:3331024231183166.
PubMed Abstract available

THOMSEN AV, Puonti O, Gaist D, Kyvik KO, et al
Investigations of the subarachnoid space as a potential link between aura and headache in migraine: A case-control MRI study.
Cephalalgia. 2023;43:3331024231170541.
PubMed Abstract available

CONSTANTINIDIS TS, Arvaniti C, Fakas N, Rudolf J, et al
The prevalence and burden of medication overuse headache in Greece.
Cephalalgia. 2023;43:3331024231184909.
PubMed Abstract available

May 2023

VAN DER AREND BWH, Verhagen IE, van Leeuwen M, van der Arend MQTP, et al
Defining migraine days, based on longitudinal E-diary data.
Cephalalgia. 2023;43:3331024231166625.
PubMed Abstract available

CHEEMA S, Mehta D, Ray JC, Hutton EJ, et al
New daily persistent headache: A systematic review and meta-analysis.
Cephalalgia. 2023;43:3331024231168089.
PubMed Abstract available

STUBBERUD A, Ingvaldsen SH, Brenner E, Winnberg I, et al
Forecasting migraine with machine learning based on mobile phone diary and wearable data.
Cephalalgia. 2023;43:3331024231169244.
PubMed Abstract available

ASHINA M, Lanteri-Minet M, Ettrup A, Christoffersen CL, et al
Efficacy and safety of eptinezumab for migraine prevention in patients with prior preventive treatment failures: subgroup analysis of the randomized, placebo-controlled DELIVER study.
Cephalalgia. 2023;43:3331024231170807.
PubMed Abstract available

VAN WELIE RF, van Welie FC, de Vries Lentsch S, Dahan A, et al
Characterizing opioid use in a Dutch cohort with migraine.
Cephalalgia. 2023;43:3331024231174160.
PubMed Abstract available

HSIAO FJ, Chen WT, Wang YF, Chen SP, et al
Identification of patients with chronic migraine by using sensory-evoked oscillations from the electroencephalogram classifier.
Cephalalgia. 2023;43:3331024231176074.
PubMed Abstract available

GULDIKEN YC, Petropoulos IN, Malik A, Malik RA, et al
Corneal confocal microscopy identifies corneal nerve fiber loss in patients with migraine.
Cephalalgia. 2023;43:3331024231170810.
PubMed Abstract available

RUSCHEWEYH R, Dresler T, Forderreuther S, Gaul C, et al
What do patients' efficacy and tolerability ratings of acute migraine medication tell us? Cross-sectional data from the DMKG Headache Registry.
Cephalalgia. 2023;43:3331024231174855.
PubMed Abstract available

STEINER TJ
Classification of migraine and tension-type headache: A response to the proposals of Olesen.
Cephalalgia. 2023;43:3331024231169240.
PubMed

SUZUKI K, Suzuki S, Shiina T, Tatsumoto M, et al
Effectiveness of three calcitonin gene-related peptide monoclonal antibodies for migraine: A 12-month, single-center, observational real-world study in Japan.
Cephalalgia. 2023;43:3331024231177649.
PubMed Abstract available

PARK CG, Na HY, Park DE, Kim HY, et al
Altered interictal serum histamine and immunoglobulin E but unchanged tryptase levels in individuals with episodic and chronic migraine.
Cephalalgia. 2023;43:3331024231178218.
PubMed Abstract available

ABU-ARAFEH I, Hershey AD, Diener HC, Tassorelli C, et al
Guidelines Update: Guidelines of the International Headache Society for controlled trials of preventive treatment of migraine in children and adolescents, 1st edition - An experience-based update.
Cephalalgia. 2023;43:3331024231178239.
PubMed Abstract available

April 2023

GIRI S, Tronvik E, Linde M, Pedersen SA, et al
Randomized controlled studies evaluating Topiramate, Botulinum toxin type A, and mABs targeting CGRP in patients with chronic migraine and medication overuse headache: A systematic review and meta-analysis.
Cephalalgia. 2023;43:3331024231156922.
PubMed Abstract available

OLESEN J, Jensen RH
The Global Campaign Against Headache and its future relation to IHS and WHO.
Cephalalgia. 2023;43:3331024231159625.
PubMed Abstract available

HAGHDOOST F, Puledda F, Garcia-Azorin D, Huessler EM, et al
Evaluating the efficacy of CGRP mAbs and gepants for the preventive treatment of migraine: A systematic review and network meta-analysis of phase 3 randomised controlled trials.
Cephalalgia. 2023;43:3331024231159366.
PubMed Abstract available

NIDDAM DM, Wu SW, Lai KL, Yang YY, et al
An altered reward system characterizes chronic migraine with medication overuse headache.
Cephalalgia. 2023;43:3331024231158088.
PubMed Abstract available

ASAWAVICHIENJINDA T, Sathitratanacheewin S, Chokesuwattanaskul R
"Wearing-off" efficacy of CGRP monoclonal antibodies for migraine prevention: A meta-analysis of randomized controlled trials.
Cephalalgia. 2023;43:3331024231161261.
PubMed Abstract available

IANNONE LF, Burgalassi A, Vigani G, Tabasso G, et al
Switching anti-CGRP(R) monoclonal antibodies in multi-assessed non-responder patients and implications for ineffectiveness criteria: A retrospective cohort study.
Cephalalgia. 2023;43:3331024231160519.
PubMed Abstract available

FAVONI V, Mascarella D, Giannini G, Bauleo S, et al
Prevalence, natural history and dynamic nature of chronic headache and medication overuse headache in Italy: The SPARTACUS study.
Cephalalgia. 2023;43:3331024231157677.
PubMed Abstract available

ASHINA M, Roos C, Li LQ, Komori M, et al
Long-term treatment with lasmiditan in patients with migraine: Results from the open-label extension of the CENTURION randomized trial.
Cephalalgia. 2023;43:3331024231161745.
PubMed Abstract available

ZHANG L, Zhou Y, Wang Y, Yang L, et al
Inhibiting PAC1 receptor internalization and endosomal ERK pathway activation may ameliorate hyperalgesia in a chronic migraine rat model.
Cephalalgia. 2023;43:3331024231163131.
PubMed Abstract available

RUSSO CV, Sacca F, Braca S, Sansone M, et al
Anti-calcitonin gene-related peptide monoclonal antibodies for the treatment of vestibular migraine: A prospective observational cohort study.
Cephalalgia. 2023;43:3331024231161809.
PubMed Abstract available

OLESEN J
Classification of migraine and tension-type headache.
Cephalalgia. 2023;43:3331024221139238.
PubMed

CROWE HM, Wesselink AK, Hatch EE, Wise LA, et al
Migraine and risk of hypertensive disorders of pregnancy: A population-based cohort study.
Cephalalgia. 2023;43:3331024231161746.
PubMed Abstract available

SAKAI F, Igarashi H, Yokoyama M, Begasse de Dhaem O, et al
Diagnosis, knowledge, perception, and productivity impact of headache education and clinical evaluation program in the workplace at an information technology company of more than 70,000 employees.
Cephalalgia. 2023;43:3331024231165682.
PubMed Abstract available

March 2023

MESSINA R, Huessler EM, Puledda F, Haghdoost F, et al
Safety and tolerability of monoclonal antibodies targeting the CGRP pathway and gepants in migraine prevention: A systematic review and network meta-analysis.
Cephalalgia. 2023;43:3331024231152169.
PubMed Abstract available

MYKLAND MS, Uglem M, Bjork MH, Matre D, et al
Effects of insufficient sleep on sensorimotor processing in migraine: A randomised, blinded crossover study of event related beta oscillations.
Cephalalgia. 2023;43:3331024221148398.
PubMed Abstract available

PULEDDA F, Tassorelli C, Diener HC
New migraine drugs.
Cephalalgia. 2023;43:3331024221144784.
PubMed

LEE MJ, Peng KP
Other primary headaches: Distinct clinical features and uncertain pathophysiology.
Cephalalgia. 2023;43:3331024221147870.
PubMed

PULEDDA F, Younis S, Huessler EM, Haghdoost F, et al
Efficacy, safety and indirect comparisons of lasmiditan, rimegepant, and ubrogepant for the acute treatment of migraine: A systematic review and network meta-analysis of the literature.
Cephalalgia. 2023;43:3331024231151419.
PubMed Abstract available

CARLSEN LN, Hansen CS, Kogelman LJA, Werge TM, et al
DNA-methylation and immunological response in medication overuse headache.
Cephalalgia. 2023;43:3331024221147482.
PubMed Abstract available

EVERS S
Cephalalgia - The early history.
Cephalalgia. 2023;43:3331024221148128.
PubMed Abstract available

MYKLAND MS, Uglem M, Stovner LJ, Brenner E, et al
Insufficient sleep may alter cortical excitability near the migraine attack: A blinded TMS crossover study.
Cephalalgia. 2023;43:3331024221148391.
PubMed Abstract available

ASHINA S, Melo-Carrillo A, Szabo E, Borsook D, et al
Pre-treatment non-ictal cephalic allodynia identifies responders to prophylactic treatment of chronic and episodic migraine patients with galcanezumab: A prospective quantitative sensory testing study (NCT04271202).
Cephalalgia. 2023;43:3331024221147881.
PubMed Abstract available

February 2023

RAFFAELLI B, De Icco R, Corrado M, Terhart M, et al
Open-label trials for CGRP-targeted drugs in migraine prevention: A narrative review.
Cephalalgia. 2023;43:3331024221137091.
PubMed Abstract available

AL-KARAGHOLI MA, Kalatharan V, Ghanizada H, Gram C, et al
Prolactin in headache and migraine: A systematic review of clinical studies.
Cephalalgia. 2023;43:3331024221136286.
PubMed Abstract available

LEE MJ, Al-Karagholi MA, Reuter U
New migraine prophylactic drugs: Current evidence and practical suggestions for non-responders to prior therapy.
Cephalalgia. 2023;43:3331024221146315.
PubMed Abstract available

HARDER AV, Terwindt GM, Nyholt DR, van den Maagdenberg AM, et al
Migraine genetics: Status and road forward.
Cephalalgia. 2023;43:3331024221145962.
PubMed Abstract available

GALLARDO VJ, Vila-Pueyo M, Pozo-Rosich P
The impact of epigenetic mechanisms in migraine: Current knowledge and future directions.
Cephalalgia. 2023;43:3331024221145916.
PubMed Abstract available

NIKOLOVA S, Chong CD, Dumkrieger GM, Li J, et al
Longitudinal differences in iron deposition in periaqueductal gray matter and anterior cingulate cortex are associated with response to erenumab in migraine.
Cephalalgia. 2023;43:3331024221144783.
PubMed Abstract available

KWON S, Lee MJ, Kim M
Epicranial headache part 1: Primary stabbing headache.
Cephalalgia. 2023;43:3331024221146985.
PubMed Abstract available

SCHRAMM S, Borner C, Reichert M, Baum T, et al
Functional magnetic resonance imaging in migraine: A systematic review.
Cephalalgia. 2023;43:3331024221128278.
PubMed Abstract available

DE BOER I, Verhagen IE, Souza MNP, Ashina M, et al
Place of next generation acute migraine specific treatments among triptans, non-responders and contraindications to triptans and possible combination therapies.
Cephalalgia. 2023;43:3331024221143773.
PubMed Abstract available

RUIZ M, Cocores A, Tosti A, Goadsby PJ, et al
Alopecia as an emerging adverse event to CGRP monoclonal antibodies: Cases Series, evaluation of FAERS, and literature review.
Cephalalgia. 2023;43:3331024221143538.
PubMed Abstract available

CHOWDHURY D, Tomar A, Deorari V, Duggal A, et al
Greater occipital nerve blockade for the preventive treatment of chronic migraine: A randomized double-blind placebo-controlled study.
Cephalalgia. 2023;43:3331024221143541.
PubMed Abstract available

LIPTON RB, Blumenfeld A, Jensen CM, Croop R, et al
Efficacy of rimegepant for the acute treatment of migraine based on triptan treatment experience: Pooled results from three phase 3 randomized clinical trials.
Cephalalgia. 2023;43:3331024221141686.
PubMed Abstract available

MEISE R, Carvalho GF, Thiel C, Luedtke K, et al
Additional effects of pain neuroscience education combined with physiotherapy on the headache frequency of adult patients with migraine: A randomized controlled trial.
Cephalalgia. 2023;43:3331024221144781.
PubMed Abstract available

TASNIM S, Wilson SG, Walsh JP, Nyholt DR, et al
Shared genetics and causal relationships between migraine and thyroid function traits.
Cephalalgia. 2023;43:3331024221139253.
PubMed Abstract available

BEGASSE DE DHAEM O, Takizawa T, Dodick DW
Long-term open-label and real-world studies of lasmiditan, ubrogepant, and rimegepant for the acute treatment of migraine attacks.
Cephalalgia. 2023;43:3331024221137092.
PubMed Abstract available

VILA-PUEYO M, Cuenca-Leon E, Queiros AC, Kulis M, et al
Genome-wide DNA methylation analysis in an antimigraine-treated preclinical model of cortical spreading depolarization.
Cephalalgia. 2023;43:3331024221146317.
PubMed Abstract available

January 2023

PATTERSON GENTILE C, Aguirre GK, Hershey AD, Szperka CL, et al
Comparison of continuous headache features in youth with migraine, new daily persistent headache, and persistent post-traumatic headache.
Cephalalgia. 2023;43:3331024221131331.
PubMed Abstract available

SCUTELNIC A, Petroulia V, Schraml L, Jung S, et al
The "index vein" as a sign for migraine aura in the emergency setting.
Cephalalgia. 2023;43:3331024221132010.
PubMed Abstract available

ACARSOY C, Fani L, Al-Hassany L, Berghout B, et al
Migraine and the risk of stroke in a middle-aged and elderly population: A prospective cohort study.
Cephalalgia. 2023;43:3331024221132008.
PubMed Abstract available

KURTH T, Rohmann JL
Studying migraine as a risk factor for stroke: The importance of working with an explicit causal framework.
Cephalalgia. 2023;43:3331024221132007.
PubMed

KLEIN BC, Miceli R, Severt L, McAllister P, et al
Safety and tolerability results of atogepant for the preventive treatment of episodic migraine from a 40-week, open-label multicenter extension of the phase 3 ADVANCE trial.
Cephalalgia. 2023;43:3331024221128250.
PubMed Abstract available

PACHECO-BARRIOS K, Velasquez-Rimachi V, Navarro-Flores A, Huerta-Rosario A, et al
Primary headache disorders in Latin America and the Caribbean: A meta-analysis of population-based studies.
Cephalalgia. 2023;43:3331024221128265.
PubMed Abstract available

CARONNA E, van den Hoek TC, Bolay H, Garcia-Azorin D, et al
Headache attributed to SARS-CoV-2 infection, vaccination and the impact on primary headache disorders of the COVID-19 pandemic: A comprehensive review.
Cephalalgia. 2023;43:3331024221131337.
PubMed Abstract available

FURIA A, Liguori R, Donadio V
Recurrent Painful Ophthalmoplegic Neuropathy: A case report with atypical features and a review of the literature.
Cephalalgia. 2023;43:3331024221133386.
PubMed Abstract available

CHWOLKA M, Goadsby PJ, Gantenbein AR
Comorbidity or combination - more evidence for cluster-migraine?
Cephalalgia. 2023;43:3331024221133383.
PubMed Abstract available

November 2022

SAMPATAKAKIS SN, Lymperopoulos L, Mavridis T, Karagiorgis G, et al
Visual snow: A systematic review and a case series.
Cephalalgia. 2022;42:1409-1419.
PubMed Abstract available

CITAK A, Kilinc E, Torun IE, Ankarali S, et al
The effects of certain TRP channels and voltage-gated KCNQ/Kv7 channel opener retigabine on calcitonin gene-related peptide release in the trigeminovascular system.
Cephalalgia. 2022;42:1375-1386.
PubMed Abstract available

BASEDAU H, Oppermann T, Gundelwein Silva E, Peng KP, et al
Galcanezumab modulates Capsaicin-induced C-fiber reactivity.
Cephalalgia. 2022;42:1331-1338.
PubMed Abstract available

October 2022

MARTINS-OLIVEIRA M, Akerman S, Holland PR, Tavares I, et al
Pharmacological modulation of ventral tegmental area neurons elicits changes in trigeminovascular sensory processing and is accompanied by glycemic changes: Implications for migraine.
Cephalalgia. 2022 Oct 18:3331024221110111. doi: 10.1177/03331024221110111.
PubMed Abstract available

RIESENBERG R, Gaul C, Stroud CE, Dong Y, et al
Long-term open-label safety study of galcanezumab in patients with episodic or chronic cluster headache.
Cephalalgia. 2022;42.
PubMed Abstract available

EVERS S, Holle-Lee D, Schankin CJ, Kull P, et al
Visual snow syndrome is probably not mediated by CGRP: A case series.
Cephalalgia. 2022;42.
PubMed Abstract available

LANGER LK, Bayley MT, Lawrence DW, Comper P, et al
Revisiting the ICHD-3 criteria for headache attributed to mild traumatic injury to the head: Insights from the Toronto Concussion Study Analysis of Acute Headaches Following Concussion.
Cephalalgia. 2022;42.
PubMed Abstract available

RAY JC, Pham X, Foster E, Cheema S, et al
The prevalence of headache disorders in Postural Tachycardia Syndrome: A systematic review and meta-analysis of the literature.
Cephalalgia. 2022;42.
PubMed Abstract available

September 2022

LANTERI-MINET M, Ducros A, Francois C, Olewinska E, et al
Effectiveness of onabotulinumtoxinA (BOTOX(R)) for the preventive treatment of chronic migraine: A meta-analysis on 10 years of real-world data.
Cephalalgia. 2022 Sep 8:3331024221123058. doi: 10.1177/03331024221123058.
PubMed Abstract available

TSAO YC, Wang YF, Fuh JL, Chen WT, et al
Non-aura visual disturbance with high visual aura rating scale scores has stronger association with migraine chronification than typical aura.
Cephalalgia. 2022 Sep 6:3331024221123074. doi: 10.1177/03331024221123074.
PubMed Abstract available

KELLIER DJ, Marquez de Prado B, Haagen D, Grabner P, et al
Development of a text message-based headache diary in adolescents and children.
Cephalalgia. 2022;42:1013-1021.
PubMed Abstract available

August 2022

MACGREGOR EA, Komori M, Krege JH, Baygani S, et al
Efficacy of lasmiditan for the acute treatment of perimenstrual migraine.
Cephalalgia. 2022 Aug 18:3331024221118929. doi: 10.1177/03331024221118929.
PubMed Abstract available

THURAIAIYAH J, Erritzoe-Jervild M, Al-Khazali HM, Schytz HW, et al
The role of cytokines in migraine: A systematic review.
Cephalalgia. 2022 Aug 12:3331024221118924. doi: 10.1177/03331024221118924.
PubMed Abstract available

HENDRIKSE ER, Rees TA, Tasma Z, Le Foll C, et al
Calcitonin receptor antibody validation and expression in the rodent brain.
Cephalalgia. 2022;42:815-826.
PubMed Abstract available

STRASSMAN AM, Melo-Carrillo A, Houle TT, Adams A, et al
Atogepant - an orally-administered CGRP antagonist - attenuates activation of meningeal nociceptors by CSD.
Cephalalgia. 2022;42:933-943.
PubMed Abstract available

THUNSTEDT DC, Schmutzer M, Fabritius MP, Thorsteinsdottir J, et al
Headache characteristics and postoperative course in Chiari I malformation.
Cephalalgia. 2022;42:879-887.
PubMed Abstract available

July 2022

IKUMI N, Cerda-Company X, Marti-Marca A, Vila-Ballo A, et al
Avoidance behaviour modulates but does not condition phonophobia in migraine.
Cephalalgia. 2022 Jul 9:3331024221111772. doi: 10.1177/03331024221111772.
PubMed Abstract available

OLESEN J
Personal view: Modelling pain mechanisms of migraine without aura.
Cephalalgia. 2022 Jul 7:3331024221111529. doi: 10.1177/03331024221111529.
PubMed Abstract available

STEINER TJ, Terwindt GM, Katsarava Z, Pozo-Rosich P, et al
Migraine-attributed burden, impact and disability, and migraine-impacted quality of life: Expert consensus on definitions from a Delphi process.
Cephalalgia. 2022 Jul 5:3331024221110102. doi: 10.1177/03331024221110102.
PubMed Abstract available

VIGANO A, Toscano M, Petolicchio B, Bianchi A, et al
Letter to the editor regarding "Efficacy and tolerability of combination treatment of topiramate and greater occipital nerve block versus topiramate monotherapy for the preventive treatment of chronic migraine: A randomized controlled trial".
Cephalalgia. 2022 Jul 3:3331024221111528. doi: 10.1177/03331024221111528.
PubMed

BRANDT RB, Cnossen VM, Doesborg PG, Coo IF, et al
Unilateral increased visual sensitivity in cluster headache: a cross-sectional study.
Cephalalgia. 2022;42:722-729.
PubMed Abstract available

ZHOU Y, Zhang F, Starcevic Manning M, Hu Z, et al
Immunogenicity of erenumab: A pooled analysis of six placebo-controlled trials with long-term extensions.
Cephalalgia. 2022;42:749-760.
PubMed Abstract available

IANNONE LF, De Cesaris F, Ferrari A, Benemei S, et al
Effectiveness of anti-CGRP monoclonal antibodies on central symptoms of migraine.
Cephalalgia. 2022 Jul 1:3331024221111526. doi: 10.1177/03331024221111526.
PubMed Abstract available

June 2022

MAKAREVICIUS G, Ryliskiene K
Successful treatment of primary headache associated with sexual activity using erenumab: Case report.
Cephalalgia. 2022;42:680-683.
PubMed Abstract available

OLIVEIRA R, Placido M, Pereira L, Machado S, et al
Headaches and the use of personal protective equipment in the general population during the COVID-19 pandemic.
Cephalalgia. 2022;42:608-617.
PubMed Abstract available

PENSATO U, Baraldi C, Favoni V, Mascarella D, et al
Detoxification vs non-detoxification before starting an anti-CGRP monoclonal antibody in medication overuse headache.
Cephalalgia. 2022;42:645-653.
PubMed Abstract available

RAIBIN K, Markus TE
Cutaneous allodynia in pediatric and adolescent patients and their mothers: A comparative study.
Cephalalgia. 2022;42:579-589.
PubMed Abstract available

May 2022

SUDAT SE, Jacobson AS, Avins AL, Lipton RB, et al
A population-health approach to characterizing migraine by comorbidity: Results from the Mindfulness and Migraine Cohort Study.
Cephalalgia. 2022 May 31:3331024221104180. doi: 10.1177/03331024221104180.
PubMed Abstract available

CHRISTENSEN CG, Techlo TR, Kogelman LJ, Wegner Thorner L, et al
Population-based prevalence of cranial autonomic symptoms in migraine and proposed diagnostic appendix criteria.
Cephalalgia. 2022 May 29:3331024221094548. doi: 10.1177/03331024221094548.
PubMed Abstract available

EVERS S, Frese A, Summ O, Husstedt IW, et al
Levetiracetam in the prophylactic treatment of episodic migraine: A prospective open label study.
Cephalalgia. 2022 May 27:3331024221103815. doi: 10.1177/03331024221103815.
PubMed Abstract available

MOUAANAKI SA, Carlsen LN, Bendtsen L, Jensen RH, et al
Treatment experiences and clinical characteristics in migraine and tension-type headache patients before the first visit to a tertiary headache center.
Cephalalgia. 2022 May 27:3331024221104178. doi: 10.1177/03331024221104178.
PubMed Abstract available

VERHAGEN IE, Spaink HA, van der Arend BW, van Casteren DS, et al
Validation of diagnostic ICHD-3 criteria for menstrual migraine.
Cephalalgia. 2022 May 6:3331024221099031. doi: 10.1177/03331024221099031.
PubMed Abstract available

HELFENSTEIN C, Strupf M, Stefke A, Fraunberger B, et al
Cyclic changes of sensory parameters in migraine patients.
Cephalalgia. 2022 May 6:3331024221097932. doi: 10.1177/03331024221097932.
PubMed Abstract available

NOSER AE, Klages KL, Gamwell KL, Brammer CN, et al
A systematic evaluation of primary headache management apps leveraging behavior change techniques.
Cephalalgia. 2022;42:510-523.
PubMed Abstract available

CHIANG CC, Shahid AH, Harriott AM, Tietjen GE, et al
Evaluation and treatment of headache associated with moyamoya disease - a narrative review.
Cephalalgia. 2022;42:542-552.
PubMed Abstract available

April 2022

GEPPETTI P, De Cesaris F, Benemei S, Cortelli P, et al
Self-administered subcutaneous diclofenac sodium in acute migraine attack: A randomized, double-blind, placebo-controlled dose-finding pilot study.
Cephalalgia. 2022 Apr 26:3331024221093712. doi: 10.1177/03331024221093712.
PubMed Abstract available

MOHAMAD SAFIAI NI, Mohamad NA, Basri H, Inche Mat LN, et al
High-frequency repetitive transcranial magnetic stimulation at dorsolateral prefrontal cortex for migraine prevention: A systematic review and meta-analysis.
Cephalalgia. 2022 Apr 17:3331024221092423. doi: 10.1177/03331024221092423.
PubMed Abstract available

PAN LH, Wang YF, Ling YH, Lai KL, et al
Pain sensitivities predict prophylactic treatment outcomes of flunarizine in chronic migraine patients: A prospective study.
Cephalalgia. 2022 Apr 11:3331024221080572. doi: 10.1177/03331024221080572.
PubMed Abstract available

NIKOLOVA S, Schwedt TJ, Li J, Wu T, et al
T2* reduction in patients with acute post-traumatic headache.
Cephalalgia. 2022;42.
PubMed Abstract available

March 2022

DI ANTONIO S, Arendt-Nielsen L, Ponzano M, Bovis F, et al
Cervical musculoskeletal impairments in the 4 phases of the migraine cycle in episodic migraine patients.
Cephalalgia. 2022 Mar 25:3331024221082506. doi: 10.1177/03331024221082506.
PubMed Abstract available

PETRUSIC I, Jovanovic V, Kovic V, Savic AM, et al
P3 latency as a biomarker for the complexity of migraine with aura: Event-related potential study.
Cephalalgia. 2022 Mar 25:3331024221090204. doi: 10.1177/03331024221090204.
PubMed Abstract available

BUTT JH, S Eddelien H, Kruuse C
The headache and aura-inducing effects of sildenafil in patients with migraine with aura.
Cephalalgia. 2022 Mar 25:3331024221088998. doi: 10.1177/03331024221088998.
PubMed Abstract available

MCALLISTER P, Kudrow D, Cady R, Hirman J, et al
Reduction in migraine-associated burden after eptinezumab treatment in patients with chronic migraine.
Cephalalgia. 2022 Mar 25:3331024221089567. doi: 10.1177/03331024221089567.
PubMed Abstract available

FERNANDEZ-DE-LAS-PENAS C, Navarro-Santana MJ, Curiel-Montero F, Plaza-Manzano G, et al
Localized and widespread pressure pain hypersensitivity in patients with episodic or chronic migraine: A systematic review and meta-analysis.
Cephalalgia. 2022 Mar 25:3331024221084217. doi: 10.1177/03331024221084217.
PubMed Abstract available

DIENER HC, McAllister P, Jurgens TP, Kessler Y, et al
Safety and tolerability of fremanezumab in patients with episodic and chronic migraine: a pooled analysis of phase 3 studies.
Cephalalgia. 2022 Mar 25:3331024221076485. doi: 10.1177/03331024221076485.
PubMed Abstract available

ASHINA M, McAllister P, Cady R, Hirman J, et al
Efficacy and safety of eptinezumab in patients with migraine and self-reported aura: Post hoc analysis of PROMISE-1 and PROMISE-2.
Cephalalgia. 2022 Mar 18:3331024221077646. doi: 10.1177/03331024221077646.
PubMed Abstract available

WANG YF, Liao YC, Tzeng YS, Chen SP, et al
Mutation screening and association analysis of NOTCH3 p.R544C in patients with migraine with or without aura.
Cephalalgia. 2022 Mar 18:3331024221080891. doi: 10.1177/03331024221080891.
PubMed Abstract available

KWON S, Gil YE, Lee MJ
Real-world efficacy of galcanezumab for the treatment of migraine in Korean patients.
Cephalalgia. 2022 Mar 18:3331024221076481. doi: 10.1177/03331024221076481.
PubMed Abstract available

MILOSEVIC N, Trajkovic JZ, Mijajlovic M, Milosevic J, et al
The burden and health care use of patients with migraine and tension-type headache in post-conflict area of Serbia.
Cephalalgia. 2022 Mar 18:3331024221082061. doi: 10.1177/03331024221082061.
PubMed Abstract available

HIRTZ C, Adam G, Raposo N, Fabre N, et al
Diagnostic utility of T2*-weighted GRE in migraine with aura attack. The cortical veins sign.
Cephalalgia. 2022 Mar 18:3331024221076484. doi: 10.1177/03331024221076484.
PubMed Abstract available

THURAIAIYAH J, Kokoti L, Al-Karagholi MA, Ashina M, et al
Involvement of adenosine signaling pathway in migraine pathophysiology: A systematic review of clinical studies.
Cephalalgia. 2022 Mar 18:3331024221077665. doi: 10.1177/03331024221077665.
PubMed Abstract available

CHOWDHURY D, Mundra A, Datta D, Duggal A, et al
Efficacy and tolerability of combination treatment of topiramate and greater occipital nerve block versus topiramate monotherapy for the preventive treatment of chronic migraine: A randomized controlled trial.
Cephalalgia. 2022 Mar 8:3331024221082077. doi: 10.1177/03331024221082077.
PubMed Abstract available

VAZ JM, Alves BM, Duarte DB, Marques LA, et al
Quality appraisal of existing guidelines for the management of headache disorders by the AGREE II's method.
Cephalalgia. 2022;42:239-249.
PubMed Abstract available

February 2022

MATAMALA-GOMEZ M, Bottiroli S, Sances G, Allena M, et al
Facial expressions modulate pain perception in patients with chronic migraine.
Cephalalgia. 2022 Feb 15:3331024221075081. doi: 10.1177/03331024221075081.
PubMed Abstract available

SEBASTIANELLI G, Abagnale C, Casillo F, Cioffi E, et al
Bimodal sensory integration in migraine: A study of the effect of visual stimulation on somatosensory evoked cortical responses.
Cephalalgia. 2022 Feb 15:3331024221075073. doi: 10.1177/03331024221075073.
PubMed Abstract available

KIM J, Park CG, Chu MK
Interictal plasma endothelin-1 levels do not change in individuals with episodic and chronic migraine.
Cephalalgia. 2022 Feb 15:3331024221075616. doi: 10.1177/03331024221075616.
PubMed Abstract available

STOVNER LJ, Hagen K, Tronvik E, Bruvik Gravdahl G, et al
FollowTheSutures: Piloting a new way to administer onabotulinumtoxinA for chronic migraine.
Cephalalgia. 2022 Feb 15:3331024211067775. doi: 10.1177/03331024211067775.
PubMed Abstract available

NUOTTAMO ME, Happola P, Artto V, Hautakangas H, et al
NCOR2 is a novel candidate gene for migraine-epilepsy phenotype.
Cephalalgia. 2022 Feb 15:3331024211068065. doi: 10.1177/03331024211068065.
PubMed Abstract available

AL-KHAZALI HM, Younis S, Al-Sayegh Z, Ashina S, et al
Prevalence of neck pain in migraine: A systematic review and meta-analysis.
Cephalalgia. 2022 Feb 15:3331024211068073. doi: 10.1177/03331024211068073.
PubMed Abstract available

MESSLINGER K, Neuhuber W, May A
Activation of the trigeminal system as a likely target of SARS-CoV-2 may contribute to anosmia in COVID-19.
Cephalalgia. 2022;42:176-180.
PubMed Abstract available

January 2022

NAJIB U, Smith T, Hindiyeh N, Saper J, et al
Non-invasive vagus nerve stimulation for prevention of migraine: The multicenter, randomized, double-blind, sham-controlled PREMIUM II trial.
Cephalalgia. 2022 Jan 9:3331024211068813. doi: 10.1177/03331024211068813.
PubMed Abstract available

MCGINLEY JS, Houts CR, Wirth RJ, Lipton RB, et al
Measuring headache day severity using multiple features in daily diary designs.
Cephalalgia. 2022;42:53-62.
PubMed Abstract available

December 2021

ELIZAGARAY-GARCIA I, Carvalho GF, Szikszay TM, Adamczyk WM, et al
Psychophysical testing in chronic migraine and chronic tension type headache: An observational study.
Cephalalgia. 2021 Dec 7:3331024211060315. doi: 10.1177/03331024211060315.
PubMed Abstract available

OLIVEIRA AB, Mercante JPP, Peres MFP, Molina MDCB, et al
Physical inactivity and headache disorders: Cross-sectional analysis in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil).
Cephalalgia. 2021;41:1467-1485.
PubMed Abstract available

NERI I, Menichini D, Monari F, Bascio LS, et al
Perinatal outcomes in women affected by different types of headache disorders: A prospective cohort study.
Cephalalgia. 2021;41:1492-1498.
PubMed Abstract available

November 2021

CHRISTENSEN SL, Rasmussen RH, Cour S, Ernstsen C, et al
Smooth muscle ATP-sensitive potassium channels mediate migraine-relevant hypersensitivity in mouse models.
Cephalalgia. 2021 Nov 24:3331024211053570. doi: 10.1177/03331024211053570.
PubMed Abstract available

MALEKIAN N, Bastani PB, Oveisgharan S, Nabaei G, et al
Preventive effect of greater occipital nerve block on patients with episodic migraine: A randomized double-blind placebo-controlled clinical trial.
Cephalalgia. 2021 Nov 17:3331024211058182. doi: 10.1177/03331024211058182.
PubMed Abstract available

CHHABRA N, Chiang CC, Di Nome MA, Houghton O, et al
Migrainous infarction of the eye: Two cases of monocular ischemic complications associated with retinal migraine.
Cephalalgia. 2021 Nov 17:3331024211056286. doi: 10.1177/03331024211056286.
PubMed Abstract available

NEVERDAHL JP, Uglem M, Matre D, Hansen JO, et al
Pain thresholds and suprathreshold pain after sleep restriction in migraine - A blinded crossover study.
Cephalalgia. 2021 Nov 17:3331024211056565. doi: 10.1177/03331024211056565.
PubMed Abstract available

TOGHA M, Martami F, Jafari E, Ariyanfar S, et al
The prevalence and characteristics of visceral autonomic symptoms among migraineurs: A population-based study.
Cephalalgia. 2021 Nov 17:3331024211056849. doi: 10.1177/03331024211056849.
PubMed Abstract available

REUTER U, Ehrlich M, Gendolla A, Heinze A, et al
Erenumab versus topiramate for the prevention of migraine - a randomised, double-blind, active-controlled phase 4 trial.
Cephalalgia. 2021 Nov 7:3331024211053571. doi: 10.1177/03331024211053571.
PubMed Abstract available

PARAKRAMAWEERA R, Evans RW, Schor LI, Pearson SM, et al
A brief diagnostic screen for cluster headache: Creation and initial validation of the Erwin Test for Cluster Headache.
Cephalalgia. 2021;41:1298-1309.
PubMed Abstract available

October 2021

HAPPOLA P, Gormley P, Nuottamo ME, Artto V, et al
Polygenic risk provides biological validity for the ICHD-3 criteria among Finnish migraine families.
Cephalalgia. 2021 Oct 14:3331024211045651. doi: 10.1177/03331024211045651.
PubMed Abstract available

OVEREEM LH, Peikert A, Hofacker MD, Kamm K, et al
Effect of antibody switch in non-responders to a CGRP receptor antibody treatment in migraine: A multi-center retrospective cohort study.
Cephalalgia. 2021 Oct 13:3331024211048765. doi: 10.1177/03331024211048765.
PubMed Abstract available

MESSINA R, Rocca MA, Valsasina P, Misci P, et al
Clinical correlates of hypothalamic functional changes in migraine patients.
Cephalalgia. 2021 Oct 13:3331024211046618. doi: 10.1177/03331024211046618.
PubMed Abstract available

KANG L, Tang W, Zhang Y, Zhang M, et al
The gut microbiome modulates nitroglycerin-induced migraine-related hyperalgesia in mice.
Cephalalgia. 2021 Oct 13:3331024211050036. doi: 10.1177/03331024211050036.
PubMed Abstract available

REUTER U, Krege JH, Lombard L, Gomez Valderas E, et al
Lasmiditan efficacy in the acute treatment of migraine was independent of prior response to triptans: Findings from the CENTURION study.
Cephalalgia. 2021 Oct 13:3331024211048507. doi: 10.1177/03331024211048507.
PubMed Abstract available

ALPUENTE A, Gallardo VJ, Asskour L, Caronna E, et al
Salivary CGRP can monitor the different migraine phases: CGRP (in)dependent attacks.
Cephalalgia. 2021 Oct 4:3331024211040467. doi: 10.1177/03331024211040467.
PubMed Abstract available

FRANK F, Ulmer H, Sidoroff V, Broessner G, et al
CGRP-antibodies, topiramate and botulinum toxin type A in episodic and chronic migraine: A systematic review and meta-analysis.
Cephalalgia. 2021;41.
PubMed Abstract available

TANHA HM, Martin NG, Whitfield JB, Nyholt DR, et al
Association and genetic overlap between clinical chemistry tests and migraine.
Cephalalgia. 2021;41.
PubMed Abstract available

GONZALEZ-QUINTANILLA V, Perez-Pereda S, Gonzalez-Suarez A, Madera J, et al
Restless legs-like syndrome as an emergent adverse event of CGRP monoclonal antibodies: A report of two cases.
Cephalalgia. 2021;41.
PubMed Abstract available

VAN CASTEREN DS, Verhagen IE, de Boer I, de Vries Lentsch S, et al
E-diary use in clinical headache practice: A prospective observational study.
Cephalalgia. 2021;41.
PubMed Abstract available

September 2021

LOBO R, Wang M, Lobo S, Bahra A, et al
Time to retire 'New daily persistent headache': Mode of onset of chronic migraine and tension-type headache.
Cephalalgia. 2021 Sep 27:3331024211044440. doi: 10.1177/03331024211044440.
PubMed Abstract available

KIM S, Lee SB, Hong YJ, Kim Y, et al
The influence of endogenous and exogenous hormonal factors on migraine in spontaneous postmenopausal women: A nationwide population-based study in South Korea.
Cephalalgia. 2021 Sep 27:3331024211044441. doi: 10.1177/03331024211044441.
PubMed Abstract available

CHOWDHURY D, Bansal L, Duggal A, Datta D, et al
TOP-PRO study: A randomized double-blind controlled trial of topiramate versus propranolol for prevention of chronic migraine.
Cephalalgia. 2021 Sep 27:3331024211047454. doi: 10.1177/03331024211047454.
PubMed Abstract available

RAFFAELLI B, Terhart M, Overeem LH, Mecklenburg J, et al
Migraine evolution after the cessation of CGRP(-receptor) antibody prophylaxis: a prospective, longitudinal cohort study.
Cephalalgia. 2021 Sep 27:3331024211046617. doi: 10.1177/03331024211046617.
PubMed Abstract available

INAN LE, Inan N
Greater occipital nerve block in migraine may have a place in migraine treatment.
Cephalalgia. 2021 Sep 23:3331024211045644. doi: 10.1177/03331024211045644.
PubMed

BOTTIROLI S, Galli F, Ballante E, Pazzi S, et al
Validity of the Severity of Dependence Scale for detecting dependence behaviours in chronic migraine with medication overuse.
Cephalalgia. 2021 Sep 20:3331024211039817. doi: 10.1177/03331024211039817.
PubMed Abstract available

PUTANANICKAL N, Gross EC, Orsini AL, Schmidt S, et al
Efficacy and safety of exogenous beta-hydroxybutyrate for preventive treatment in episodic migraine: A single-centred, randomised, placebo-controlled, double-blind crossover trial.
Cephalalgia. 2021 Sep 20:3331024211043792. doi: 10.1177/03331024211043792.
PubMed Abstract available

CORRIGENDUM to 'Anti-CGRP monoclonal antibodies for migraine prevention: A systematic review and likelihood to help or harm analysis'.
Cephalalgia. 2021 Sep 14:3331024211042798. doi: 10.1177/03331024211042798.
PubMed

SCHWEDT TJ, Lipton RB, Ailani J, Silberstein SD, et al
Time course of efficacy of atogepant for the preventive treatment of migraine: Results from the randomized, double-blind ADVANCE trial.
Cephalalgia. 2021 Sep 14:3331024211042385. doi: 10.1177/03331024211042385.
PubMed Abstract available

IKEGAMI D, Navratilova E, Yue X, Moutal A, et al
A prolactin-dependent sexually dimorphic mechanism of migraine chronification.
Cephalalgia. 2021 Sep 12:3331024211039813. doi: 10.1177/03331024211039813.
PubMed Abstract available

August 2021

LIPTON RB, Dodick DW, Kudrow D, Reuter U, et al
Reduction in migraine pain intensity in patients treated with erenumab: A post hoc analysis of two pivotal randomized studies.
Cephalalgia. 2021 Aug 18:3331024211028966. doi: 10.1177/03331024211028966.
PubMed Abstract available

TFELT-HANSEN P, Jorgensen K, Diener HC
Doubtful use of placebo following placebo in recent controlled trials of lasmiditan and ubrogepant for the treatment of migraine attacks.
Cephalalgia. 2021 Aug 18:3331024211029939. doi: 10.1177/03331024211029939.
PubMed Abstract available

CHRISTENSEN SL, Rasmussen RH, Ernstsen C, La Cour S, et al
CGRP-dependent signalling pathways involved in mouse models of GTN- cilostazol- and levcromakalim-induced migraine.
Cephalalgia. 2021 Aug 18:3331024211038884. doi: 10.1177/03331024211038884.
PubMed Abstract available

PENG KP, Schellong M, May A
Aura in trigeminal autonomic cephalalgia is probably mediated by comorbid migraine with aura.
Cephalalgia. 2021 Aug 18:3331024211030499. doi: 10.1177/03331024211030499.
PubMed Abstract available

GIL-GOUVEIA R, Oliveira AG
Are PROMs passing the message? A reflection with real-life migraine patients.
Cephalalgia. 2021 Aug 18:3331024211034509. doi: 10.1177/03331024211034509.
PubMed Abstract available

ROZEN TD, Bhatt AA
Reversible cerebral vasoconstriction syndrome developing after an erenumab injection for migraine prevention.
Cephalalgia. 2021 Aug 18:3331024211037277. doi: 10.1177/03331024211037277.
PubMed Abstract available

BEIER D, Callesen HE, Carlsen LN, Birkefoss K, et al
Manual joint mobilisation techniques, supervised physical activity, psychological treatment, acupuncture and patient education in migraine treatment. A systematic review and meta-analysis.
Cephalalgia. 2021 Aug 18:3331024211034489. doi: 10.1177/03331024211034489.
PubMed Abstract available

MARTINELLI D, Arceri S, De Icco R, Allena M, et al
BoNT-A efficacy in high frequency migraine: an open label, single arm, exploratory study applying the PREEMPT paradigm.
Cephalalgia. 2021 Aug 18:3331024211034508. doi: 10.1177/03331024211034508.
PubMed Abstract available

MCGINLEY JS, Savord A, Houts CR, Wirth RJ, et al
What do people want to know about "Growing Up with Migraine"? Results of a preference survey of people with lived experience to guide future research.
Cephalalgia. 2021 Aug 18:3331024211038526. doi: 10.1177/03331024211038526.
PubMed Abstract available

AL-HASSANY L, Vries T, Carpay JA, MaassenVanDenBrink A, et al
Could erectile dysfunction be a side effect of CGRP inhibition? A case report.
Cephalalgia. 2021 Aug 18:3331024211037304. doi: 10.1177/03331024211037304.
PubMed Abstract available

REIDY BL, Peugh J, Hershey AD, Coffey CS, et al
Trajectory of treatment response in the child and adolescent migraine prevention (CHAMP) study: A randomized clinical trial.
Cephalalgia. 2021 Aug 17:3331024211033551. doi: 10.1177/03331024211033551.
PubMed Abstract available

MILOSEVIC N, Trajkovic JZ, Mijajlovic M, Milosevic J, et al
The first prevalence study of primary headaches in adults in a post-conflict area of Serbia.
Cephalalgia. 2021;41:959-967.
PubMed Abstract available

HUTCHINSON S, Silberstein SD, Blumenfeld AM, Lipton RB, et al
Safety and efficacy of ubrogepant in participants with major cardiovascular risk factors in two single-attack phase 3 randomized trials: ACHIEVE I and II.
Cephalalgia. 2021;41:979-990.
PubMed Abstract available

MEHTA DG, Garza I, Robertson CE
Two hundred and forty-eight cases of visual snow: A review of potential inciting events and contributing comorbidities.
Cephalalgia. 2021;41:1015-1026.
PubMed Abstract available

July 2021

TFELT-HANSEN P
Naratriptan is as effective as sumatriptan for the treatment of migraine attacks when used properly. A mini-review.
Cephalalgia. 2021 Jul 18:3331024211028959. doi: 10.1177/03331024211028959.
PubMed Abstract available

ROXAS A JR, Quiles LE, Wang SJ
Delivery of care for migraine in the Asian Oceanian region: A cross-sectional study.
Cephalalgia. 2021 Jul 18:3331024211024153. doi: 10.1177/03331024211024153.
PubMed Abstract available

CERAMI C, Crespi C, Bottiroli S, Santi GC, et al
High perceived isolation and reduced social support affect headache impact levels in migraine after the Covid-19 outbreak: A cross sectional survey on chronic and episodic patients.
Cephalalgia. 2021 Jul 13:3331024211027568. doi: 10.1177/03331024211027568.
PubMed Abstract available

AKERMAN S, Salvemini D, Romero-Reyes M
Targeting reactive nitroxidative species in preclinical models of migraine.
Cephalalgia. 2021 Jul 13:3331024211017884. doi: 10.1177/03331024211017884.
PubMed Abstract available

DAVIDSSON OB, Olofsson IA, Kogelman LJ, Andersen MA, et al
Twenty-five years of triptans - a nationwide population study.
Cephalalgia. 2021;41:894-904.
PubMed Abstract available

June 2021

MACKENZIE KD, Stratton JR
Response to letter to the Editor: Assessing migraine therapeutics.
Cephalalgia. 2021 Jun 30:3331024211021563. doi: 10.1177/03331024211021563.
PubMed

XU C, Bussiere J
Assessing migraine therapeutics.
Cephalalgia. 2021 Jun 30:3331024211021569. doi: 10.1177/03331024211021569.
PubMed

WANG SJ, Roxas AA Jr, Saravia B, Kim BK, et al
Randomised, controlled trial of erenumab for the prevention of episodic migraine in patients from Asia, the Middle East, and Latin America: The EMPOwER study.
Cephalalgia. 2021 Jun 25:3331024211024160. doi: 10.1177/03331024211024160.
PubMed Abstract available

GERSTL L, Tadych N, Heinen F, Kainz C, et al
Migraine and the development of additional psychiatric and pain disorders in the transition from adolescence to adulthood.
Cephalalgia. 2021 Jun 23:3331024211021792. doi: 10.1177/03331024211021792.
PubMed Abstract available

BENBOW T, Cairns BE
Dysregulation of the peripheral glutamatergic system: A key player in migraine pathogenesis?
Cephalalgia. 2021 Jun 20:3331024211017882. doi: 10.1177/03331024211017882.
PubMed Abstract available

FRESE A, Summ O, Evers S
CGRP release in an experimental human trigeminal pain model.
Cephalalgia. 2021 Jun 20:3331024211017250. doi: 10.1177/03331024211017250.
PubMed Abstract available

LENGYEL M, Hajdu D, Dobolyi A, Rosta J, et al
TRESK background potassium channel modifies the TRPV1-mediated nociceptor excitability in sensory neurons.
Cephalalgia. 2021;41:827-838.
PubMed Abstract available

CONSTANTINIDIS TS, Arvaniti C, Fakas N, Rudolf J, et al
A population-based survey for disabling headaches in Greece: Prevalence, burden and treatment preferences.
Cephalalgia. 2021;41:810-820.
PubMed Abstract available

May 2021

COHEN-BARAK O, Radivojevic A, Jones A, Fiedler-Kelly J, et al
Dose selection for fremanezumab (AJOVY) phase 3 pediatric migraine studies using pharmacokinetic data from a pediatric phase 1 study and a population pharmacokinetic modeling and simulation approach.
Cephalalgia. 2021 May 17:3331024211007789. doi: 10.1177/03331024211007789.
PubMed Abstract available

GANTENBEIN AR, Agosti R, Gobbi C, Flugel D, et al
Impact on monthly migraine days of discontinuing anti-CGRP antibodies after one year of treatment - a real-life cohort study.
Cephalalgia. 2021 May 17:3331024211014616. doi: 10.1177/03331024211014616.
PubMed Abstract available

TASSORELLI C, Diener HC, Silberstein SD, Dodick DW, et al
Guidelines of the International Headache Society for clinical trials with neuromodulation devices for the treatment of migraine.
Cephalalgia. 2021 May 14:3331024211010413. doi: 10.1177/03331024211010413.
PubMed Abstract available

WILKINS AJ, Haigh SM, Mahroo OA, Plant GT, et al
Photophobia in migraine: A symptom cluster?
Cephalalgia. 2021 May 14:3331024211014633. doi: 10.1177/03331024211014633.
PubMed Abstract available

PAZDERA L, Cohen JM, Ning X, Campos VR, et al
Fremanezumab for the Preventive Treatment of Migraine: Subgroup Analysis by Number of Prior Preventive Treatments with Inadequate Response.
Cephalalgia. 2021 May 14:3331024211008401. doi: 10.1177/03331024211008401.
PubMed Abstract available

LIPTON RB, Burstein R, Buse DC, Dodick DW, et al
Efficacy of erenumab in chronic migraine patients with and without ictal allodynia.
Cephalalgia. 2021 May 13:3331024211010305. doi: 10.1177/03331024211010305.
PubMed Abstract available

CORRIGENDUM to 'Safety findings from Phase 3 lasmiditan studies for acute treatment of migraine: Results from SAMURAI and SPARTAN'.
Cephalalgia. 2021 May 5:3331024211015848. doi: 10.1177/03331024211015848.
PubMed

DIENER HC, Ashina M, Ritter S, Paiva Da Silva Lima G, et al
Erenumab prevents the occurrence of migraine attacks and not just migraine days: Post-hoc analyses of a phase III study.
Cephalalgia. 2021 May 3:3331024211010308. doi: 10.1177/03331024211010308.
PubMed Abstract available

YOUNG AS, Nham B, Bradshaw AP, Calic Z, et al
Clinical, oculographic, and vestibular test characteristics of vestibular migraine.
Cephalalgia. 2021 May 2:3331024211006042. doi: 10.1177/03331024211006042.
PubMed Abstract available

SCHWEDT TJ, Sahai-Srivastava S, Murinova N, Birlea M, et al
Determinants of pain interference and headache impact in patients who have chronic migraine with medication overuse: Results from the MOTS trial.
Cephalalgia. 2021 May 2:3331024211006903. doi: 10.1177/03331024211006903.
PubMed Abstract available

April 2021

CHONG CD, Berisha V, Ross K, Kahn M, et al
Distinguishing persistent post-traumatic headache from migraine: Classification based on clinical symptoms and brain structural MRI data.
Cephalalgia. 2021 Apr 29:333102421991819. doi: 10.1177/0333102421991819.
PubMed Abstract available

POHL H, Benemei S, Garcia-Azorin D, Dixon J, et al
Time lost due to an attack - a novel patient-reported outcome measure for acute migraine treatments.
Cephalalgia. 2021 Apr 19:3331024211006048. doi: 10.1177/03331024211006048.
PubMed Abstract available

RAOOF N, Hoffmann J
Diagnosis and treatment of idiopathic intracranial hypertension.
Cephalalgia. 2021;41:472-478.
PubMed Abstract available

CERIANI CE, Silberstein SD
Headache and rhinosinusitis: A review.
Cephalalgia. 2021;41:453-463.
PubMed Abstract available

March 2021

ROTHROCK JF, Diener HC
Headache secondary to cerebrovascular disease.
Cephalalgia. 2021 Mar 18:333102421999045. doi: 10.1177/0333102421999045.
PubMed Abstract available

ZHANG Y, Zhao X, Wang Y, Dong Z, et al
Prevalence and characteristics of cough headache in a Chinese respiratory clinic.
Cephalalgia. 2021;41:366-374.
PubMed Abstract available

VINOGRADOVA LV, Suleymanova EM, Medvedeva TM
Transient loss of interhemispheric functional connectivity following unilateral cortical spreading depression in awake rats.
Cephalalgia. 2021;41:353-365.
PubMed Abstract available

February 2021

SHAH R, Assis F, Narasimhan B, Khachadourian V, et al
Trans-nasal high-flow dehumidified air in acute migraine headaches: A randomized controlled trial.
Cephalalgia. 2021 Feb 25:333102421997766. doi: 10.1177/0333102421997766.
PubMed Abstract available

WANG X, Yin Z, Lian Y, Xu Y, et al
Premonitory symptoms in migraine from China: A multi-clinic study of 4821 patients.
Cephalalgia. 2021 Feb 25:333102421997850. doi: 10.1177/0333102421997850.
PubMed Abstract available

BHAKTA M, Vuong T, Taura T, Wilson DS, et al
Migraine therapeutics differentially modulate the CGRP pathway.
Cephalalgia. 2021 Feb 24:333102420983282. doi: 10.1177/0333102420983282.
PubMed Abstract available

SOLLMANN N, Schandelmaier P, Weidlich D, Borner C, et al
Patients with episodic migraine show increased T2 values of the trapezius muscles - an investigation by quantitative high-resolution magnetic resonance imaging.
Cephalalgia. 2021 Feb 20:333102421996374. doi: 10.1177/0333102421996374.
PubMed Abstract available

SOUTHWELL J, Afridi SK
The burden of migraine on acute and emergency services in a London teaching hospital.
Cephalalgia. 2021 Feb 18:333102420981734. doi: 10.1177/0333102420981734.
PubMed Abstract available

DE TOMMASO M, Delussi M, Gentile E, Ricci K, et al
Effect of single dose Erenumab on cortical responses evoked by cutaneous a-delta fibers: A pilot study in migraine patients.
Cephalalgia. 2021 Feb 16:333102421996345. doi: 10.1177/0333102421996345.
PubMed Abstract available

DRELLIA K, Kokoti L, Deligianni CI, Papadopoulos D, et al
Anti-CGRP monoclonal antibodies for migraine prevention: A systematic review and likelihood to help or harm analysis.
Cephalalgia. 2021 Feb 10:333102421989601. doi: 10.1177/0333102421989601.
PubMed Abstract available

WIENHOLTZ NKF, Christensen CE, Zhang DG, Coskun H, et al
Early treatment with sumatriptan prevents PACAP38-induced migraine: A randomised clinical trial.
Cephalalgia. 2021 Feb 10:333102420975395. doi: 10.1177/0333102420975395.
PubMed Abstract available

TCHIVILEVA IE, Ohrbach R, Fillingim RB, Lim PF, et al
Effect of comorbid migraine on propranolol efficacy for painful TMD in a randomized controlled trial.
Cephalalgia. 2021 Feb 9:333102421989268. doi: 10.1177/0333102421989268.
PubMed Abstract available

ASHINA M, Reuter U, Smith T, Krikke-Workel J, et al
Randomized, controlled trial of lasmiditan over four migraine attacks: Findings from the CENTURION study.
Cephalalgia. 2021 Feb 4:333102421989232. doi: 10.1177/0333102421989232.
PubMed Abstract available

LISICKI M, Figuerola ML, Bonamico L, Lew D, et al
The prevalence of migraine in Argentina: A reappraisal.
Cephalalgia. 2021 Feb 1:333102421989262. doi: 10.1177/0333102421989262.
PubMed Abstract available

CHO S, Cho SJ, Lee MJ, Park JW, et al
Clinical characteristics of pre-attack symptoms in cluster headache: A large series of Korean patients.
Cephalalgia. 2021;41:227-236.
PubMed Abstract available

January 2021

DIENER HC, Ashina M, Durand-Zaleski I, Kurth T, et al
Health technology assessment for the acute and preventive treatment of migraine: A position statement of the International Headache Society.
Cephalalgia. 2021 Jan 20:333102421989247. doi: 10.1177/0333102421989247.
PubMed Abstract available

CATARCI T
Occipital ischaemic stroke after visual snow phenomenon - a case report.
Cephalalgia. 2021 Jan 12:333102420985444. doi: 10.1177/0333102420985444.
PubMed Abstract available

VERHAGEN IE, van Casteren DS, Lentsch SV, Terwindt GM, et al
Effect of lockdown during COVID-19 on migraine: A longitudinal cohort study.
Cephalalgia. 2021 Jan 11:333102420981739. doi: 10.1177/0333102420981739.
PubMed Abstract available

KARSAN N, Perez-Rodriguez A, Nagaraj K, Bose PR, et al
The migraine postdrome: Spontaneous and triggered phenotypes.
Cephalalgia. 2021 Jan 10:333102420975401. doi: 10.1177/0333102420975401.
PubMed Abstract available

MELO-CARRILLO A, Strassman AM, Schain AJ, Adams AM, et al
Combined onabotulinumtoxinA/atogepant treatment blocks activation/sensitization of high-threshold and wide-dynamic range neurons.
Cephalalgia. 2021;41:17-32.
PubMed Abstract available

LEHMAN LL, Bruccoleri R, Danehy A, Swanson J, et al
Adverse effects of erenumab on cerebral proliferative angiopathy: A case report.
Cephalalgia. 2021;41:122-126.
PubMed Abstract available

December 2020

ILJAZI A, Ashina H, Zhuang ZA, Lopez Lopez C, et al
Hypersensitivity to calcitonin gene-related peptide in chronic migraine.
Cephalalgia. 2020 Dec 15:333102420981666. doi: 10.1177/0333102420981666.
PubMed Abstract available

BEGASSE DE DHAEM O, Gharedaghi MH, Bain P, Hettie G, et al
Identification of work accommodations and interventions associated with work productivity in adults with migraine: A scoping review.
Cephalalgia. 2020 Dec 10:333102420977852. doi: 10.1177/0333102420977852.
PubMed Abstract available

STRANG-KARLSSON S, Alenius S, Nasanen-Gilmore P, Nurhonen M, et al
Migraine in children and adults born preterm: A nationwide register linkage study.
Cephalalgia. 2020 Dec 9:333102420978357. doi: 10.1177/0333102420978357.
PubMed Abstract available

POZO-ROSICH P, Coppola G, Pascual J, Schwedt TJ, et al
How does the brain change in chronic migraine? Developing disease biomarkers.
Cephalalgia. 2020 Dec 8:333102420974359. doi: 10.1177/0333102420974359.
PubMed Abstract available

SCHRAMM S, Tenhagen I, Schmidt B, Holle-Lee D, et al
Prevalence and risk factors of migraine and non-migraine headache in older people - results of the Heinz Nixdorf Recall study.
Cephalalgia. 2020 Dec 3:333102420977183. doi: 10.1177/0333102420977183.
PubMed Abstract available

IRIMIA P, Martinez-Valbuena I, Minguez-Olaondo A, Dominguez-Vivero C, et al
Interictal amylin levels in chronic migraine patients: A case-control study.
Cephalalgia. 2020 Dec 3:333102420977106. doi: 10.1177/0333102420977106.
PubMed Abstract available

LIPTON RB, Tepper SJ, Silberstein SD, Kudrow D, et al
Reversion from chronic migraine to episodic migraine following treatment with erenumab: Results of a post-hoc analysis of a randomized, 12-week, double-blind study and a 52-week, open-label extension.
Cephalalgia. 2020 Dec 3:333102420973994. doi: 10.1177/0333102420973994.
PubMed Abstract available

WOOD ME, Burch RC, Hernandez-Diaz S
Polypharmacy and comorbidities during pregnancy in a cohort of women with migraine.
Cephalalgia. 2020 Dec 3:333102420975394. doi: 10.1177/0333102420975394.
PubMed Abstract available

GROENKE BR, Daline IH, Nixdorf DR
SUNCT/SUNA: Case series presenting in an orofacial pain clinic.
Cephalalgia. 2020 Dec 3:333102420977292. doi: 10.1177/0333102420977292.
PubMed Abstract available

November 2020

GOADSBY PJ, Blumenfeld AM, Lipton RB, Dodick DW, et al
Time course of efficacy of ubrogepant for the acute treatment of migraine: Clinical implications.
Cephalalgia. 2020 Nov 26:333102420970523. doi: 10.1177/0333102420970523.
PubMed Abstract available

GHANIZADA H, Iljazi A, Ashina H, Do TP, et al
Nocebo response in human models of migraine: A systematic review and meta-analysis of randomized, double-blind, placebo-controlled, two-way crossover trials in migraine without aura and healthy volunteers.
Cephalalgia. 2020 Nov 26:333102420970489. doi: 10.1177/0333102420970489.
PubMed Abstract available

ASHINA M, Dolezil D, Bonner JH, Zhou L, et al
A phase 2, randomized, double-blind, placebo-controlled trial of AMG 301, a pituitary adenylate cyclase-activating polypeptide PAC1 receptor monoclonal antibody for migraine prevention.
Cephalalgia. 2020 Nov 24:333102420970889. doi: 10.1177/0333102420970889.
PubMed Abstract available

VAN CASTEREN DS, Verhagen IE, Onderwater GL, MaassenVanDenBrink A, et al
Sex differences in prevalence of migraine trigger factors: A cross-sectional study.
Cephalalgia. 2020 Nov 17:333102420974362. doi: 10.1177/0333102420974362.
PubMed Abstract available

WANG SJ, Wu JW
Reversion from chronic migraine to episodic migraine: A new outcome measure.
Cephalalgia. 2020 Nov 17:333102420974004. doi: 10.1177/0333102420974004.
PubMed

GOLLION C, Gazagnes J, Fabry V, Barbieux-Guillot M, et al
Atrial fibrillation and migraine with aura in young adults with ischemic stroke.
Cephalalgia. 2020 Nov 17:333102420970880. doi: 10.1177/0333102420970880.
PubMed Abstract available

CARVALHO GF, Luedtke K, Szikszay TM, Bevilaqua-Grossi D, et al
Muscle endurance training of the neck triggers migraine attacks.
Cephalalgia. 2020 Nov 17:333102420970184. doi: 10.1177/0333102420970184.
PubMed Abstract available

LACKOVIC J, Price TJ, Dussor G
De novo protein synthesis is necessary for priming in preclinical models of migraine.
Cephalalgia. 2020 Nov 17:333102420970514. doi: 10.1177/0333102420970514.
PubMed Abstract available

MASTRIA G, Mancini V, Cesare MD, Puma M, et al
Prevalence and characteristics of Alice in Wonderland Syndrome in adult migraineurs: Perspectives from a tertiary referral headache unit.
Cephalalgia. 2020 Nov 9:333102420968245. doi: 10.1177/0333102420968245.
PubMed Abstract available

DODICK DW, Doty EG, Aurora SK, Ruff DD, et al
Medication overuse in a subgroup analysis of phase 3 placebo-controlled studies of galcanezumab in the prevention of episodic and chronic migraine.
Cephalalgia. 2020 Nov 3:333102420966658. doi: 10.1177/0333102420966658.
PubMed Abstract available

KOPRUSZINSKI CM, Thornton P, Arnold J, Newton P, et al
Characterization and preclinical evaluation of a protease activated receptor 2 (PAR2) monoclonal antibody as a preventive therapy for migraine.
Cephalalgia. 2020 Nov 1:333102420966581. doi: 10.1177/0333102420966581.
PubMed Abstract available

PETRUSIC I, Zidverc-Trajkovic J
Redefining types of migraine aura.
Cephalalgia. 2020 Nov 1:333102420970186. doi: 10.1177/0333102420970186.
PubMed

LEVINE A, Vanderah TW, Largent-Milnes TM
An underrepresented majority: A systematic review utilizing allodynic criteria to examine the present scarcity of discrete animal models for episodic migraine.
Cephalalgia. 2020 Nov 1:333102420966984. doi: 10.1177/0333102420966984.
PubMed Abstract available

October 2020

LINSTRA KM, Ibrahimi K, van Casteren DS, Wermer MJ, et al
Pain perception in women with menstrually-related migraine.
Cephalalgia. 2020 Oct 21:333102420966977. doi: 10.1177/0333102420966977.
PubMed Abstract available

ERNSTSEN C, Christensen SL, Olesen J, Kristensen DM, et al
No additive effect of combining sumatriptan and olcegepant in the GTN mouse model of migraine.
Cephalalgia. 2020 Oct 15:333102420963857. doi: 10.1177/0333102420963857.
PubMed Abstract available

RIST PM, Bernstein C, Kowalski M, Osypiuk K, et al
Multimodal chiropractic care for migraine: A pilot randomized controlled trial.
Cephalalgia. 2020 Oct 13:333102420963844. doi: 10.1177/0333102420963844.
PubMed Abstract available

ZELE AJ, Dey A, Adhikari P, Feigl B, et al
Melanopsin hypersensitivity dominates interictal photophobia in migraine.
Cephalalgia. 2020 Oct 12:333102420963850. doi: 10.1177/0333102420963850.
PubMed Abstract available

Migraine Trust Virtual 2020 - Author index.
Cephalalgia. 2020;40.
PubMed

PERES MF, Evers S
Using social media and search engine data in headache research.
Cephalalgia. 2020;40:1274-1275.
PubMed

September 2020

ZAGAMI AS, Shaikh S, Mahns D, Lambert GA, et al
A potential role for two brainstem nuclei in craniovascular nociception and the triggering of migraine headache.
Cephalalgia. 2020 Sep 29:333102420960039. doi: 10.1177/0333102420960039.
PubMed Abstract available

KOPRUSZINSKI CM, Navratilova E, Swiokla J, Dodick DW, et al
A novel, injury-free rodent model of vulnerability for assessment of acute and preventive therapies reveals temporal contributions of CGRP-receptor activation in migraine-like pain.
Cephalalgia. 2020 Sep 26:333102420959794. doi: 10.1177/0333102420959794.
PubMed Abstract available

SMITH JH
Have you ever experienced a headache of any kind?
Cephalalgia. 2020;40:1132-1133.
PubMed

July 2020

LIU Y, Wang M, Bian X, Qiu E, et al
Proposed modified diagnostic criteria for recurrent painful ophthalmoplegic neuropathy: Five case reports and literature review.
Cephalalgia. 2020 Jul 28:333102420944872. doi: 10.1177/0333102420944872.
PubMed Abstract available

December 2019

HVEDSTRUP J, Kolding LT, Younis S, Ashina M, et al
Ictal neck pain investigated in the interictal state - a search for the origin of pain.
Cephalalgia. 2019 Dec 18:333102419896369. doi: 10.1177/0333102419896369.
PubMed Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Migraine is free of charge.